ADMA Biologics, Inc. is a biopharmaceutical company based in Ramsey, New Jersey, specializing in the development and commercialization of plasma-derived therapies for immunodeficiencies and infectious diseases. The company employs proprietary production technologies to produce high-quality therapeutic products, thereby enhancing patient outcomes in a significant healthcare market. With a strong pipeline and a dedication to addressing critical medical needs, ADMA is well-positioned for growth in the evolving landscape of biopharmaceuticals.